Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemay005 in Moderate to Severe Chronic Plaque Psoriasis (Phase II)
CTR20190759Phase 2Completed
- Sponsor
- Hainan Hailing
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mufemilast in psoriasis, sponsored by Hainan Hailing. Started May 2019; status: completed.
02
Drugs
mufemilast
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20190759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190759.